These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19436304)

  • 1. Plasma phyto-oestrogens and prostate cancer in the European Prospective Investigation into Cancer and Nutrition.
    Travis RC; Spencer EA; Allen NE; Appleby PN; Roddam AW; Overvad K; Johnsen NF; Olsen A; Kaaks R; Linseisen J; Boeing H; Nöthlings U; Bueno-de-Mesquita HB; Ros MM; Sacerdote C; Palli D; Tumino R; Berrino F; Trichopoulou A; Dilis V; Trichopoulos D; Chirlaque MD; Ardanaz E; Larranaga N; Gonzalez C; Suárez LR; Sánchez MJ; Bingham S; Khaw KT; Hallmans G; Stattin P; Rinaldi S; Slimani N; Jenab M; Riboli E; Key TJ
    Br J Cancer; 2009 Jun; 100(11):1817-23. PubMed ID: 19436304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating isoflavone and lignan concentrations and prostate cancer risk: a meta-analysis of individual participant data from seven prospective studies including 2,828 cases and 5,593 controls.
    Perez-Cornago A; Appleby PN; Boeing H; Gil L; Kyrø C; Ricceri F; Murphy N; Trichopoulou A; Tsilidis KK; Khaw KT; Luben RN; Gislefoss RE; Langseth H; Drake I; Sonestedt E; Wallström P; Stattin P; Johansson A; Landberg R; Nilsson LM; Ozasa K; Tamakoshi A; Mikami K; Kubo T; Sawada N; Tsugane S; Key TJ; Allen NE; Travis RC
    Int J Cancer; 2018 Dec; 143(11):2677-2686. PubMed ID: 29971774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phyto-oestrogens and risk of prostate cancer in Scottish men.
    Heald CL; Ritchie MR; Bolton-Smith C; Morton MS; Alexander FE
    Br J Nutr; 2007 Aug; 98(2):388-96. PubMed ID: 17403269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediagnostic concentrations of plasma genistein and prostate cancer risk in 1,605 men with prostate cancer and 1,697 matched control participants in EPIC.
    Travis RC; Allen NE; Appleby PN; Price A; Kaaks R; Chang-Claude J; Boeing H; Aleksandrova K; Tjønneland A; Johnsen NF; Overvad K; Ramón Quirós J; González CA; Molina-Montes E; Sánchez MJ; Larrañaga N; Castaño JM; Ardanaz E; Khaw KT; Wareham N; Trichopoulou A; Karapetyan T; Rafnsson SB; Palli D; Krogh V; Tumino R; Vineis P; Bueno-de-Mesquita HB; Stattin P; Johansson M; Fedirko V; Norat T; Siddiq A; Riboli E; Key TJ
    Cancer Causes Control; 2012 Jul; 23(7):1163-71. PubMed ID: 22674291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of prospective associations between plasma and urinary phytoestrogens and risk of prostate or colorectal cancer in the European Prospective into Cancer-Norfolk study.
    Ward H; Chapelais G; Kuhnle GG; Luben R; Khaw KT; Bingham S
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2891-4. PubMed ID: 18843034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in the CYP19 gene may affect the positive correlations between serum and urine phytoestrogen metabolites and plasma androgen concentrations in men.
    Low YL; Taylor JI; Grace PB; Dowsett M; Folkerd E; Doody D; Dunning AM; Scollen S; Mulligan AA; Welch AA; Luben RN; Khaw KT; Day NE; Wareham NJ; Bingham SA
    J Nutr; 2005 Nov; 135(11):2680-6. PubMed ID: 16251630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case-control study of phyto-oestrogens and breast cancer.
    Ingram D; Sanders K; Kolybaba M; Lopez D
    Lancet; 1997 Oct; 350(9083):990-4. PubMed ID: 9329514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma phytoestrogens and subsequent breast cancer risk.
    Verheus M; van Gils CH; Keinan-Boker L; Grace PB; Bingham SA; Peeters PH
    J Clin Oncol; 2007 Feb; 25(6):648-55. PubMed ID: 17200150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine phyto-oestrogen metabolites are not significantly associated with risk of type 2 diabetes: the Singapore Chinese health study.
    Talaei M; Lee BL; Ong CN; van Dam RM; Yuan JM; Koh WP; Pan A
    Br J Nutr; 2016 May; 115(9):1607-15. PubMed ID: 26949260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lignans and isoflavonoids in plasma and prostatic fluid in men: samples from Portugal, Hong Kong, and the United Kingdom.
    Morton MS; Chan PS; Cheng C; Blacklock N; Matos-Ferreira A; Abranches-Monteiro L; Correia R; Lloyd S; Griffiths K
    Prostate; 1997 Jul; 32(2):122-8. PubMed ID: 9215400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary phytoestrogens and risk of prostate cancer in Jamaican men.
    Jackson MD; McFarlane-Anderson ND; Simon GA; Bennett FI; Walker SP
    Cancer Causes Control; 2010 Dec; 21(12):2249-57. PubMed ID: 20924663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast, colorectal, and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition-Norfolk in relation to phytoestrogen intake derived from an improved database.
    Ward HA; Kuhnle GG; Mulligan AA; Lentjes MA; Luben RN; Khaw KT
    Am J Clin Nutr; 2010 Feb; 91(2):440-8. PubMed ID: 20007303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phyto-oestrogens and colorectal cancer risk: a systematic review and dose-response meta-analysis of observational studies.
    Jiang R; Botma A; Rudolph A; Hüsing A; Chang-Claude J
    Br J Nutr; 2016 Dec; 116(12):2115-2128. PubMed ID: 28091359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phytoestrogen concentrations in serum from Japanese men and women over forty years of age.
    Morton MS; Arisaka O; Miyake N; Morgan LD; Evans BA
    J Nutr; 2002 Oct; 132(10):3168-71. PubMed ID: 12368413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer.
    Magee PJ; Rowland IR
    Br J Nutr; 2004 Apr; 91(4):513-31. PubMed ID: 15035679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary phytoestrogen excretion and prostate cancer risk: a nested case-control study in the Multiethnic Cohort.
    Park SY; Wilkens LR; Franke AA; Le Marchand L; Kakazu KK; Goodman MT; Murphy SP; Henderson BE; Kolonel LN
    Br J Cancer; 2009 Jul; 101(1):185-91. PubMed ID: 19536097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating concentrations of folate and vitamin B12 in relation to prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition study.
    Johansson M; Appleby PN; Allen NE; Travis RC; Roddam AW; Egevad L; Jenab M; Rinaldi S; Kiemeney LA; Bueno-de-Mesquita HB; Vollset SE; Ueland PM; Sánchez MJ; Quirós JR; González CA; Larrañaga N; Chirlaque MD; Ardanaz E; Sieri S; Palli D; Vineis P; Tumino R; Linseisen J; Kaaks R; Boeing H; Pischon T; Psaltopoulou T; Trichopoulou A; Trichopoulos D; Khaw KT; Bingham S; Hallmans G; Riboli E; Stattin P; Key TJ
    Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):279-85. PubMed ID: 18268110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phyto-oestrogens and cardiovascular disease risk.
    van der Schouw YT; de Kleijn MJ; Peeters PH; Grobbee DE
    Nutr Metab Cardiovasc Dis; 2000 Jun; 10(3):154-67. PubMed ID: 11006924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variations in plasma phytoestrogen concentrations in European adults.
    Peeters PH; Slimani N; van der Schouw YT; Grace PB; Navarro C; Tjonneland A; Olsen A; Clavel-Chapelon F; Touillaud M; Boutron-Ruault MC; Jenab M; Kaaks R; Linseisen J; Trichopoulou A; Trichopoulos D; Dilis V; Boeing H; Weikert C; Overvad K; Pala V; Palli D; Panico S; Tumino R; Vineis P; Bueno-de-Mesquita HB; van Gils CH; Skeie G; Jakszyn P; Hallmans G; Berglund G; Key TJ; Travis R; Riboli E; Bingham SA
    J Nutr; 2007 May; 137(5):1294-300. PubMed ID: 17449595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective study of plasma enterolactone and prostate cancer risk (Sweden).
    Stattin P; Bylund A; Biessy C; Kaaks R; Hallmans G; Adlercreutz H
    Cancer Causes Control; 2004 Dec; 15(10):1095-102. PubMed ID: 15801493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.